[89Zr]ZrDFO-CR011 positron emission tomography correlates with response to glycoprotein non-metastatic melanoma B-targeted therapy in triple negative breast cancer

2022 ◽  
pp. molcanther.0590.2021
Author(s):  
Supum Lee ◽  
Alessandra Cavaliere ◽  
Jean-Dominique Gallezot ◽  
Tibor Keler ◽  
Sharon K Michelhaugh ◽  
...  
Cancers ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 2978
Author(s):  
Chia-Jung Li ◽  
Yen-Dun Tony Tzeng ◽  
Yi-Han Chiu ◽  
Hung-Yu Lin ◽  
Ming-Feng Hou ◽  
...  

Triple negative breast cancer (TNBC) is a heterogeneous tumor characterized by early recurrence, high invasion, and poor prognosis. Currently, its treatment includes chemotherapy, which shows a suboptimal efficacy. However, with the increasing studies on TNBC subtypes and tumor molecular biology, great progress has been made in targeted therapy for TNBC. The new developments in the treatment of breast cancer include targeted therapy, which has the advantages of accurate positioning, high efficiency, and low toxicity, as compared to surgery, radiotherapy, and chemotherapy. Given its importance as cancer treatment, we review the latest research on the subtypes of TNBC and relevant targeted therapies.


2004 ◽  
Vol 91 (11) ◽  
pp. 1398-1409 ◽  
Author(s):  
A. M. Byrne ◽  
A. D. K. Hill ◽  
S. J. Skehan ◽  
E. W. McDermott ◽  
N. J. O'Higgins

Sign in / Sign up

Export Citation Format

Share Document